Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

52.31 -0.12 (-0.23%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,187,706
Open 52.04
Bid (Size) 52.21 (2)
Ask (Size) 52.28 (4)
Prev. Close 52.43
Today's Range 51.25 - 52.37
52wk Range 38.93 - 61.71
Shares Outstanding 5,606,688,356
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Hot Stocks: Tickers Moved By Traders on 'Fast Money: Halftime Report'
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. 
Via Benzinga
Why Is Novavax (NVAX) Stock Up 10% Today?
Interest around the potential for another Covid-19 surge this winter, as well as vaccine efficacy, has NVAX stock soaring today. 
Via InvestorPlace

Performance

YTD
-7.66%
-7.66%
1 Month
-0.70%
-0.70%
3 Month
+2.69%
+2.69%
6 Month
-7.66%
-7.66%
1 Year
+31.66%
+31.66%

More News

Read More
Stock Market Rally Under Pressure; Micron, GM, Nike, RH Warn: Weekly Review
Via Investor's Business Daily
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
Via Benzinga
Pfizer Seeks Complete Approval For Paxlovid For High Risk COVID-19 Patients
Via Benzinga
Why BioNTech Stock Is Surging
Via Benzinga
Why Pfizer Stock Is Rising Today
Via Benzinga
This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices
Via Benzinga
PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid
Via InvestorPlace
Will Palantir, Pfizer And Oracle Stocks Continue Higher In This Trend?
Via Benzinga
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
Via Investor's Business Daily
Cough Remedies Market 2022-2029 Global Industry Trends, Growth Rate and Revenue : Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis
Via SBWire
Topics Supply Chain
Exposures Supply Chain
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Via Benzinga
Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30
Via Benzinga
US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine
Via Benzinga
Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™
From Pfizer Inc.
Via Business Wire
Check Out What Whales Are Doing With PFE
Via Benzinga
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
Efficacy Of Pfizer's Paxlovid COVID Drug Crashes, According To New NIH-Funded Study
Via Benzinga
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
Via InvestorPlace
Market Briefing For Wednesday, May 29, 2022
Via Talk Markets
FDA Eyes New Vaccine Composition In Response To COVID Mutations: Here's What You Need To Know
Via Benzinga
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
Via Investor's Business Daily
Why Corcept's Pill — And Stock — Is Getting Renewed Attention After Abortion Ruling
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.